Kura Oncology, Inc. (KURA)
Kura Oncology Market Cap : 781.56M for June 9, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Celldex Therapeutics, Inc. | 1.979B |
| Catalyst Pharmaceuticals, Inc. | 3.829B |
| Exelixis, Inc. | 13.44B |
| Gilead Sciences, Inc. | 155.81B |
| Capricor Therapeutics, Inc. | 1.500B |
Market Cap Related Metrics
| PS Ratio | 10.81 |
| PEG Ratio | -0.0437 |
| Price to Book Value | 7.244 |
| Price | 8.805 |
| Earnings Yield | -38.02% |
| PEGY Ratio | -0.0437 |